XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Adjustment
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Non- controlling Interests
Balances at Beginning at Dec. 31, 2021 $ 728,941   $ 1,470 $ 312,538 $ 475,262   $ (55,950) $ (5,791) $ 1,412
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to noncontrolling interests and Tompkins Financial Corporation 23,304       23,273       31
Other comprehensive income (loss) (79,899)           (79,899)    
Subtotal comprehensive income (loss) attributable to noncontrolling interests and Tompkins Financial Corporation (56,595)                
Cash dividends (8,335)       (8,335)        
Net exercise of stock options (42)     (42)          
Common stock repurchased and returned to unissued status (10,370)   (13) (10,357)          
Stock-based compensation expense 945     945          
Shares issued for employee stock ownership plan 2,951   4 2,947          
Directors deferred compensation plan 0     (149)       149  
Restricted stock activity (3)   (1) (2)          
Balances at Ending at Mar. 31, 2022 657,492   1,460 305,880 490,200   (135,849) (5,642) 1,443
Balances at Beginning at Dec. 31, 2022 617,390 $ (65) 1,456 302,763 526,727 $ (65) (208,689) (6,279) 1,412
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income attributable to noncontrolling interests and Tompkins Financial Corporation 19,412       19,381       31
Other comprehensive income (loss) 20,843           20,843    
Subtotal comprehensive income (loss) attributable to noncontrolling interests and Tompkins Financial Corporation 40,255                
Cash dividends (8,712)       (8,712)        
Net exercise of stock options (108)   (108)          
Stock-based compensation expense 1,045     1,045          
Directors deferred compensation plan 0     (303)       303  
Restricted stock activity (40)   (40)          
Balances at Ending at Mar. 31, 2023 $ 649,765   $ 1,456 $ 303,357 $ 537,331   $ (187,846) $ (5,976) $ 1,443